Long-term viability of thick three-dimensional engineered tissue constructs is a major challenge. Addressing it requires development of vessel-like network that will allow the survival of the construct in vitro and its integration in vivo owing to improved vascularization after implantation. Resulting from work of various research groups, several approaches were developed aiming engineered tissue vascularization: (1) embodiment of angiogenesis growth factors in the polymeric scaffolds for prolonged release, (2) coculture of endothelial cells with target tissue cells and angiogenesis signaling cells, (3) use of microfabrication methods for creating designed channels for allowing nutrients to flow and=or for directing endothelial cells attachment, and (4) decellularization of organs and blood vessels for creating extracellular matrix. A synergistic effect is expected by combining several of these approaches as already demonstrated in some of the latest studies. Current paper reviews the progress in each approach and recent achievements toward vascularization of engineered tissues.
Introduction
T issue engineering is an interdisciplinary field developed as an attempt to resolve shortage in tissues and organs for transplantation therapy. Although significant progress in combining cells and polymer scaffolds was achieved, the state-of-the-art technology and biology knowhow still needs to be recruited. The need for a vasculature, to deliver nutrients and oxygen and to remove waste materials, is particularly important when engineering threedimensional (3D) thick tissues like the heart, liver, and kidney. Transplanted cells compete for oxygen and other nutrients between themselves and with native cells being recruited for inflammatory response. Because oxygen diffusion is slower than oxygen consumption, oxygen is the limiting factor in cell survival. As a result, few cells tolerate distances of <200 mm from a blood vessel. Sensitive cells like islets show necrosis when the diffusion distance exceeds *100 mm, while cartilage cells present the other extreme, maintaining viability in grafts thicker than 1 mm. 1 So far, growing thick, viable engineered constructs is still a major challenge, which includes addressing the need of mammalian cells to be located adjacent to blood vessels. 2 In vivo implanted constructs' survival depends on rapid vascularization allowing better engraftment and, later, its integration. However, the host's vascularization is not sufficient to feed the implant, especially during the first period after implantation. In addition, endothelial vessels were shown to provide inductive signals being critical for liver and pancreatic development, 3, 4 and for cardiac cell maturation beyond their nutrition role. 5 Thus, promoting vascularization of engineered tissues is critical both for supporting organization of the cells into the desired tissue and for its survival-hence, widely investigated. 6 Major advances in the last decade in the field of tissue engineering brought significant tools for understanding the mechanisms and parameters of blood vessel network formation, and angiogenesis enhancement for therapeutic strategies. These can be sorted into three main approaches for 3D tissue culture: (1) growth factor (GF)-releasing scaffolds, (2) coculture of target and endothelial cells (EC) in 3D scaffolds, and (3) engineered vasculature using microfabrication techniques or decellularized matrices.
The current review describes recent developments of the above approaches to vascularization of engineered tissues.
Vasculogenesis and Angiogenesis-Background
Vasculogenesis, the formation of new vessels from EC, and their progenitors (angioblasts), 7 takes place mainly during embryogenesis. However, many studies reported its existence in adults as well. [8] [9] [10] Vasculogenesis and angiogenesis, sprouting of capillaries from preexisting blood vessels, are multifactor processes driven by numerous GF, released at a precise time and concentration.
A variety of angiogenic factors have been tested aiming angiogenesis=vasculogenesis of EC by promoting the desirable process.
Among various angiogenesis-related GF, vascular endothelial growth factor (VEGF) is the most investigated one. 2010 of angiogenesis. They are involved in EC migration and in the maturation process of the nascent vessels. 12 Moreover, VEGF and its receptors function as vascular permeability factors. 13 Additional angiogenic factors include the fibroblast growth factors (FGF), platelet-derived growth factors (PDGF), angiopoeitins, and the transforming growth factors (TGF).
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Several models of angiogenesis have been developed to investigate its mechanism under well-defined in vitro conditions. The most common in vitro models are the 3D gel assays obtained by culturing EC in gels made of various extracellular matrix (ECM) compounds, such as type I collagen, [14] [15] [16] [17] [18] fibrin, 19, 20 fibronectin, 21 and basement membrane extracellular extracts or Matrigel. 22, 23 It was revealed by Davis group [16] [17] [18] that the biological mechanisms in developing stable, branched capillaries network are involved with ECM compounds (collagen, fibrin, and laminin), integrins (a2b1, a1b1, avb3, a5b1, and a6b1), and cytoskeleton proteins (actin, microtubule, and interfilament) interactions. However, in many cases, the 3D environment itself is not enough to promote mature and stable capillary-like network. Therefore, angiogenic factors are added to these 3D models for enhancement of capillary-like tube formation from EC lines.
Studies of embryonic development in the 1990s uncovered new facts of angiogenesis, and the crucial role of several GF manipulating it and controlling the organization of EC into capillary-like structures.
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GF-Releasing Scaffolds
The use of acellular=cellular tissue-engineered scaffolds, which can deliver GF in a controlled manner, is an attractive and popular approach to induce controlled vasculogenesis= angiogenesis. Such scaffolds, designed for controlled-release GF delivery, are more efficient in vivo, as they enable local delivery and prolonged effect of the GF.
The field of GF delivering scaffolds can be divided into two main areas: (1) a single GF delivery and (2) multiple GF sustained delivery in a controlled manner. Both approaches are discussed here.
Single GF-releasing scaffolds
Using biodegradable porous scaffolds incorporating GF is a common and simple procedure utilizing the degradation process of the polymer for controlled release of GF. Angiogenesis, manifested in higher capillary number, and blood vessels density as well as maturity, was achieved in ischemic hind limb after transplantation of porous poly (lactic glycol) (PLG) incorporating VEGF 27 or basic fibroblast growing factor (bFGF)-releasing gelatin hydrogel. 28 Similarly, polydimethylsiloxane-tetraethoxysilane (PDMS-TEOS) hybridcontaining VEGF promoted angiogenesis and tissue restoration of artificial brain defects. 29 Further, VEGF was directly attached to PLG scaffolds for rapid release or was preencapsulated in PLG microspheres for delayed release in vivo. 30 After 2 weeks of subcutaneous implantation, the releasing VEGF scaffolds significantly enhanced capillaries' growth. A similar effect was reported for irradiated defects in rats. VEGF-releasing poly (lactic-co-glycolic acid) (PLGA) scaffolds were implanted in the area of irradiated defects and revealed a twofold increase in blood vessel formation. In addition, 30% increase in functionality was indicated by Laser Doppler perfusion imaging and histological analysis. 31 The above results encouraged further development of porous scaffold fabrication methods suitable for GF incorporation; one such method is gas foaming, where VEGF was directly incorporated into the polymer solution or combined with alginate beads before being mixed with the polymer solution. 32 Also, attempting to improve GF incorporation, several researchers have tried to attach GF to heparinized porous scaffolds. 33, 34 The use of GF incorporated into microspheres was also described as a useful way of controlling GF release from 3D scaffolds. Perets et al. 35 created unique tiny microspheres of PLGA containing bFGF incorporated into an alginate scaffold. In vivo experiments showed that this technique resulted in capillaries that can penetrate much deeper than the controls. Moreover, capillary density was higher after 21 days than after 10 days, indicating that the goal of prolonged angiogenesis enhancement was achieved.
The effect of growth factor-reduced Matrigel (GFRM) and growth factor-containing Matrigel being incorporated into the pores of PLGA scaffolds was investigated in aortic ring assay. 36 Matrigel-free scaffolds served as controls. Growth factor-containing Matrigel stimulated the development of tubular vessel network with a significantly increased sprout area and density compared with GFRM. The former also accelerated and improved in vivo the ingrowth of new blood vessels into the scaffolds in comparison with GFRM and the control group.
Hydrogels are another group of scaffold materials that are also widely used. Mechanical signals, such as repeated compressive loads, were shown to induce VEGF release from alginate hydrogels. 37 Thus, being subjected to mechanical stimulation, VEGF incorporated hydrogels exhibited in vivo significantly higher blood vessel density than similar hydrogels, which neither were mechanically stimulated nor did contain VEGF. Like VEGF-releasing PLGA scaffold, sustained local delivery of VEGF from injectable hydrogel leads to substantially increased angiogenesis in ischemic murine hind limbs. 38 bFGF was mixed with peptide-amphiphile aqueous solution to create nanofiber injectable scaffolds being capable of releasing bFGF in vivo for a long period. The resulting induced angiogenesis, as indicated by the amount of tissue hemoglobin, was significantly higher when using the combination of the peptide-amphiphile scaffolds with encapsulated bFGF. 39 The use of bioactive glasses to coat VEGF-releasing scaffolds was suggested for prolonged localization in the affected area. 40 Indeed, this unique system resulted in significantly improved blood vessel density after 2 weeks.
Scaffolds releasing multi-GF combinations
Nowadays, it is recognized that one GF administration is insufficient to induce formation of mature blood vessels, as combined GF release is required to stabilize EC tubes. Carmeliet and Conway 41 and Richardson et al. 42 described a unique system delivering VEGF and PDGF-BB with distinct kinetics from a porous polymer scaffold. 41, 42 This system contains VEGF being mixed with polymer particles, resulting in rapid release of the GF. In the second phase, degradation of the polymer led to release of PDGF-BB, which was preencapsulated in microspheres embedded in the scaffold. Likewise, incorporated VEGF-A in alginate hydrogels encouraged formation of capillary vessels similarly to incorporation of PDFG-BB, but incorporation of both tremendously increased the density of capillaries (Fig. 1) . 42, 43 In vivo experiments using porous collagen scaffolds linked to heparin with one or two GF (VEGF and FGF2) emphasized the importance of dual GF administration. It was found that only the addition of both angiogenic factors results in a mature vasculature formation. 44 Stemming thereof, 3D fibrin hydrogel designed to store and release VEGF and bFGF for enhanced wound healing was recently developed. 45 An approach to control vasculogenesis was introduced, as two-layered scaffolds were produced, each incorporating one GF or a combination of GF (VEGF and=or PDGF). 46 This controlled GF release system enabled to explore the effects of multi-GF administration compared to a single GF, and=or scaffolds with no GF. Indeed, multi-GF administration was much more productive, and resulted in blood vessels of more mature phenotype and higher density.
Vascularization Enhancement by Coculture
Complex signaling within a tissue or organ, composed of several cell types, is known to regulate variable functioning of the tissue and its ordered architecture. Accordingly, angiogenesis is a complex process known to result from a sequential set of events that can be modulated in vivo by both cell-cell and cell-matrix interactions. [47] [48] [49] [50] Intensive biological in vitro studies of D'Amore group have demonstrated that cellular interactions between EC and mesenchymal precursor cells, regulated by TGF-b and PDGF signaling, are essential for differentiation into smooth muscle cells (SMC) (as expressed by the exclusive protein SM22a in adult SMC). The differentiated cells are recruited to EC capillaries for generation of stable blood vessels. 51, 52 In addition to cellular interactions, cells act reciprocally through direct physical contacts for facilitating anchorage, communication, and permeability. These generate TGF-b that promotes ECM production, growth arrest, and vessel stabilization. Likewise, it was reported that in the absence of associated pericytes or smooth muscle cells, the nascent EC tube is unstable and is prone to regression. 53 Hence, coculture of target tissue cells together with EC for promoting vascularization is a promising approach based on the above.
Yet, coculture for promoting angiogenesis was demonstrated to be an uneasy task, as cocultivation of EC together with fibroblasts, pericytes, or vascular SMC in fibrin gel did not lead to capillary networks, 54 while younger or embryonic fibroblasts were able to support such endothelial organization in other gel systems. Nevertheless, one of the first studies investigating the effect of coculture dealt with a model of tumor angiogenesis, where bovine aortic endothelial cells were cocultured with tumor cells of seven glioma cell lines in vitro. 55 Four of them expressed high levels of bFGF mRNA and induced tube formation by bovine aortic endothelial cells. The latter, cocultured with the other three cell lines that poorly expressed bFGF, did not organize to tube structure. A coculture system comprising murine peritoneal macrophages and intervertebral disk tissue from herniated disk resulted in increased macrophage VEGF expression upon exposure to the disk tissue. Hence, it demonstrated vascularization enhancement via GF expression. 56 Addition of the conditioned medium from the coculture system to the disk tissue enhanced vascular tubule formation.
Similarly, VEGF and bFGF expressed by preadipocytes cocultured with EC in fibrin matrix were shown to induce migration and proliferation of the EC, opposed to apoptosis of the EC when monocultured on identical matrix. 57 Endothelialized human tissue-engineered skin consisting of capillary network was introduced by coculturing keratinocytes, dermal fibroblasts, and human umbilical vein endothelial cells (HUVEC) on 3D porous chitosan=collagen. 47 Capillary tubes were clearly observed starting from 15 days in the coculture system while being absent in the monoculture of each cell type. The spontaneous capillary network formation was explained by the cell-cell contacts of HUVEC with fibroblasts and the cell-matrix interactions. Specifically, it was referred to the ability of fibroblasts to produce high amounts of human ECM, when cultured in 3D porous structure, and the keratinocytes ability to express VEGF in culture. The vascularized engineered skin was then implanted in mice, and the mouse blood in the in vitro generated vasculature only after 4 days. 58 Likewise, blood vessel networks proven to be stable and functional for 1 year in vivo were developed from HUVEC cocultured with mesenchymal precursor cells in a 3D fibronectin-type I collagen gel. The mesenchymal cells differentiated into mural cells through heterotypic interaction with the EC, enabling the physical support needed for the stabilization of the developing in vitro blood vessel network. 59 The differentiation potential of a 3D coculture system was shown also as mouse myoblasts were mixed with human embryonic stem cell (hESC)-derived EC or with HUVEC. 60 The mixed cells were seeded on highly porous 3D biodegradable poly-(L-lactic acid) PLLA=PLGA sponge-like scaffolds. It was found that when both myoblasts and EC (either hESC-derived or HUVEC) were cocultured, the EC organized into tubular structures in between the myoblasts and throughout the construct, forming vessel networks within the in vitro engineered muscle tissue. Self-organization of EC to vessel network was demonstrated also by coculture of HUVEC and human foreskin fibroblasts that were seeded within PLLA=PLGA sponge-like scaffolds ( Fig. 2A-C ) (Lesman and Levenberg, unpublished data). When embryonic fibroblasts were added to the culture together with myoblasts, vascularization of the engineered muscle was strongly promoted (Fig. 2D, E) (Francis et al., unpublished data; Koffler and Levenberg, unpublished data). This was evidenced by increased total area of EC and the number and size of endothelial lumens, compared with constructs with no embryonic fibroblasts. The morphological results were consistent with VEGF expression of the different cultures. The vascularized engineered muscle tissues were assessed in vivo by implantation in three different model mice, and exhibited continuous differentiation. The constructs were permeated with the host blood vessels. Based on these results, the ability to engineer cardiac tissue based on hESC-derived cardiomyocytes (hESC-CM) was evaluated. 61 hESC-CM were seeded together with hESC-derived EC (hESC-EC), or HUVEC with or without embryonic fibroblasts. The authors generated synchronously contracting engineered human cardiac tissue containing endothelial vessel networks, derived from embryonic stem cells. The fibroblasts stabilized the formed vessels by restricting EC death and increasing their proliferation. Moreover, the presence of EC capillaries augmented cardiomyocyte proliferation without interfering their orientation or alignment (Fig. 2F, G 
The major role of vascular GF induced by one of the cell lines in the coculture is clearly a joint motive in all above studies. Hence, the role of culturing different cell lines in contact has been questioned. Kitahara et al. 62 examined the specific contribution of coculture by investigating the function of mesangial cells (MC) in endothelial vascularization. They seeded a coculture of HUVEC and human MC onto 3D Matrigel (contact system). For comparison, they used also a noncontact system, where MC were cultured within an intercup chamber, which prevented physical contact with the EC, but allowed sharing the culture medium. They found that HUVEC cultured in contact with MC developed remarkable capillary-like networks. These were observed in the noncontact system as well, but were much less developed. The control system consisted solely of HUVEC, and the GF-free medium barely formed any capillary-like networks. Accordingly, VEGF proved to be an important mediator in vascularization, as it was secreted from MC in both test systems. 56, 57 The effect of microenvironment was also demonstrated, as arterial and venous EC lost their arteriovenous asymmetrical ephrin B2 expression pattern, when being moved to an in vitro culturing system. 63 Moreover, FGF receptor 2 and ligand were shown to be secreted from HUVEC and human umbilical artery smooth muscle cells as if both are one entity; thus, FGF receptor 2 was suggested to have a paracrine function. 64 In support, it was shown that a direct cell-cell contact of HUVEC and SMC plays an important role in inducing vascularization. Cocultured neural progenitor cells and brainderived immortalized microvascular EC on macroporous hydrogel showed significantly higher blood vessel density after 6 weeks in vivo; this is in opposition to the separately cultured cells although no GFP-positive neural progenitors were found. 65 Hence, it demonstrated the importance of direct interaction between cells. Moreover, after the said time period, the vessels of the cocultured system remained stable, while regression of vessels appeared in the brain-derived immortalized microvascular EC monoculture.
Engineering a Vasculature Using Microfabrication Techniques
Owing to the recognized necessity in vascularization, scaffolds having a potential to support it were developed. A variety of methods were used for scaffold fabrication-for example, porous polymeric scaffolds manufactured by the salt leach method, and gas foamed polymers. An example of a new approach is the assembly of small gel modules containing the cells of interest and covered with EC before assembly into larger constructs. 66 Because vital organs contain dense vasculature with diverse dimensions (from a few micrometers to a few millimeters), microfabrication methods were introduced as well for that purpose. Such is a nonwoven silk fibroin net allowing adhesion and spreading of EC along the individual fibers. 67 Micro Electro Mechanical Systems (MEMS) is a special case of microfabrication methods found applicable for the fabrication of capillary networks.
Vacanti, Borenstein, and coworkers [68] [69] [70] [71] pioneered the concept of engineering a vasculature using microfabrication techniques. Their first approach was to culture cells on patterned silicon and Pyrex wafers (rigid and brittle materials), where the channels remained open in 2D configuration. 69 Improvement of this technology yielded the second approach-close 3D channels and the use of soft biocompatible materials like PDMS and poly-(glycerol sebacate) (PGS). 62, 68 Briefly, the basic process for the second approach consists of the following stages: a photoresist is spin-coated on clean silicon wafers and then exposed to UV light, and the network pattern is etched using reactive ion etching. The remaining resist is stripped away by chemical solutions. A molten polymer solution can now be poured into the network mold to create one side of the channels. Last, the patterned and nonpatterned polymers are bound together by oxygen plasma to create the 3D closed channels. The capillary network was fabricated from PDMS 62 or from PGS. 68 Because PDMS is transparent, the cell-cultivating processes can be visually observed. EC were cultured for up to 2 weeks and maintained their character in these confined geometries. After seeding with EC the channels were perfused with a syringe pump at a physiological flow rate, which resulted in attachment and proliferation of EC in the microchannel scaffolds. Photoresist melting and soft lithography techniques were also used for replicating complementary plates with circular channels, where bovine EC were successfully cultured. 72 Many researchers have fabricated microchannels using MEMS techniques: Wang et al. 73 used a simple and inexpen- 
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sive lithograph approach, in which polymethyl metacrylate was selected to be the substrate. A negative photoresist was employed to form the microchannel structure. Compared to the silicon or glass micromachining, the photoresist-based photolithography needed no further etching process. A soft lithographic process for making PDMS microchannels using the negative photoresist as the molding tool could be employed as well (Fig. 3A, B) . The resultant microvessels were later seeded with bovine EC according to static and dynamic seeding protocols. 74 Ryu et al. 75 presented a microfabrication-based 3D scaffolding method for biodegradable polymers, such as polylactic acid, polyglycolic acid, and the copolymer (PLGA). Microchannels were fabricated by a molding process, when a polymer on top of microfeatures in the mold locally flows and fills the vacant space (Fig. 3C) . Afterward, a microbonding process of two microstructured polymer surfaces was initiated for the creation of 3D structures. The biocompatibility of the presented methods was confirmed by culturing human coronary artery EC on the constructed scaffolds.
A unique method for a microperfusion device for highcell-density in vitro tissue culture was demonstrated. The device served to perfuse brain tissue with a medium when cultured in vitro rather than as a template to culture EC (Fig. 3D) . 76 A microfabrication technique to build artificial blood capillaries on both polycarbonate and biocompatible material, such as PLGA (Fig. 3E) , was developed. 77 It included lithography of silicon wafer or stainless steel substrate, electroforming to make the mold, spin coating of PLGA dissolved in adequate organic solvents on the mold, and, finally, O 2 plasma etching to join the PLGA and the glass. The vascular network was successfully used to cultivate bovine EC.
A breakthrough in the field of microchannels for engineered vasculature was achieved by Cho et al., 78 who fabricated microfluidic channels network directly embedded within bovine chondrocyte-seeded alginate gel. They used soft lithography of a silicon stamp as a master on which hydrogel with definitive microstructure can be molded, after which, cell seeded alginate was injected and crosslinked. Using this method two matching parts of the scaffold were fabricated, and eventually pressed against each other to form a sealed structure, allowing the flow of solutions through the microchannels.
Another unique technique is the laser-guided direct writing (LGDW) utilizing a weakly focused beam to trap and deliver particles, including living cells, to a nonabsorbing surface.
LGDW was used for patterning HUVEC on Matrigel along a desired form. After the HUVEC were self-assembled into vascular structures along the predesigned pattern (Fig.  4) , they were cocultured with hepatocytes (HC), resulting in an aggregated tubular structure similar to hepatic sinusoid. 79 
Use of Natural Structures
Because much effort is required for mimicking nature, development of methods for reuse of natural structures is an evolving approach. Ott et al. 80 created a whole-heart scaffold with intact 3D geometry and vasculature by decellularizing cadaveric hearts using detergents for coronary perfusion. The decellularized scaffolds were then seeded with cardiac cells and rat aortic EC, which were cocultured under simulated physiological conditions required for organ maturation. It was shown that the fiber composition and orientation of the myocardial ECM were preserved (Fig. 5a) . Moreover, blood flow was demonstrated shortly after transplantation of the decellularized whole rat heart, when the host aorta was unclamped (Fig. 5b) . The EC were seeded by medium perfusion; after 7 days, they formed single layers in both larger and smaller coronary vessels. Due to those successful stages, the recellularized heart construct was contracting and drug responsive after 8 days in culture.
Porcine jejunal segment was decellularized in a similar technique, and seeded with porcine microvascular endothelial cells. Porcine HC were seeded on the vascularized scaffold, and the resulting coculture resulted in 3D HC clusters, in multiple cell layers lining the generated microvascular endothelial cell-seeded capillary structures. 81 Hence, the potential use of natural decellularized organs was demonstrated.
Summary and Conclusions
Vascularization is essential for both proper development of the tissue in vitro and engraftment after implantation in vivo. Vascularization of thick engineered tissue constructs is a major challenge toward culture of tissues intended for organ replacement therapy. Due to its complexity, achieving proper vascularization in vitro and in vivo requires a combination of expertise in the field of developmental biology and engineering of vessel-like networks. As detailed in the current review, the scope of the research work aiming vascularization of engineered tissues is impressive. It is conducted following several main approaches: (1) usage of various angiogenesis GF embedded in advance in the scaffolds, for controlled release and delivery; (2) coculture of EC, target tissue cells and fibroblasts for spontaneous induction of angiogenesis; (3) fabrication of channels mimicking blood vessel networks using state-of-the-art microfabrication techniques or decellularized organ matrices. Hence, for culture and implantation of viable tissues, an integration of all the different aspects must be regarded-that is, a tissue construct consisting of adequate scaffold material and geometry, cocultured EC and pericytes, GF, and a template for vasculature (Fig. 6) . Given all these, one can expect that the tissue construct will eventually join the existing blood vessels of the living organ and assimilate in the native tissue. Although vast research has been done in the field, and considerable progress was achieved, significant obstacles and challenges still require to be addressed. In addition, the demonstrated engineered solutions still need to be proved as adequate for clinical use.
